tiprankstipranks
Trending News
More News >

Guardian Pharmacy sees Q4 revenue ~$338.6M, consensus $320.52M

Q4 Net Income is expected to be between $10.1M-$11.1M, an expected decrease between $3.5M-$4.5M year-over-year, primarily attributable to expected income tax provision expense between $5M-$6M. Adjusted EBITDA is expected to be approximately $25.9M, an expected increase of approximately 30.3% year-over-year. “We’re proud to report that we ended the year on a strong note, exceeding our expectations for the fourth quarter and year ended December 31, 2024. The outperformance was driven by strong organic growth, acquisitions, and the new benefit of the seasonal trend related to conducting vaccine clinics in certain long-term care facilities we serve. Looking ahead, we enter 2025 well-positioned for success and we remain committed to meeting the needs of all of the residents we serve,” said Fred Burke, President & CEO of Guardian.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue